Lung Cancer Study Leads to New Screening Program

Lung Cancer Screening
Print icon

Need to know more about lung cancer? Click here to download your free guide.  

Following national research data demonstrating substantial improvements in lung cancer mortality, Hartford HealthCare  researchers completed their own study exploring the feasibility of lung cancer screening in Connecticut.

In a landmark study sponsored by the National Cancer Institute, researchers with the National Lung Screening Trial screened more than 53,000 current or former heavy smokers and concluded that participants undergoing  low-dose helical computed tomography (CT) scans were 15 to 20 percent less likely to die from lung cancer than those being screened by standard chest X-rays. A CT scan provides an image of the entire chest, allowing doctors to identify nodules that might be a sign of cancer.

A team from the Hartford HealthCare Cancer Institute, led by principal investigator Dr. Andrew Salner, used the national findings as the foundation for its Lung Cancer Screening Study. The team – which included Drs. Thomas Farquhar and John Volpe from Hartford Hospital, Dr. Eric Gorny from The Hospital of Central Connecticut, Dr. James Carroll from MidState Medical Center and Dr. Robert Bundy from Windham Hospital – visited Lahey Clinic, an early adopter and research center for lung cancer screening. The goal was to draw on best practices and create a screening study that could be offered to eligible patients at all Hartford HealthCare hospitals.

Need to know more about lung cancer? Click here to download your free guide.  

From 2014 to 2016, almost 1,000 people were enrolled in the Lung Cancer Screening Study and underwent annual CT screenings. Active smokers were also counseled for smoking cessation. Of the study participants:

  • 6 percent had suspicious findings.
  • 124 were found to have unrelated abnormalities, most of which were benign, of other tissues such as the thyroid, breast, aorta, heart, mediastinum, kidney, rib and chest wall or liver.
  • 16 had a new primary lung malignancy; 75 percent of these had stage 1 disease.

“An essential philosophy of cancer investigation is to recognize that, in order to learn something, we must ask the right question,” said Dr. Salner, who is also medical director of the Cancer Institute at Hartford Hospital. “In order to answer it, we must design the right research strategy.

“Our research project not only allowed us to gain needed experience with this new modality, but also helped us implement a new program under the rigor of a research project, with a primary care referral orientation and the ability to reach all the communities we serve.”

As a result, primary care physicians in the community can refer patients to the Cancer Institute Lung Cancer Screening Program at the closest Hartford HealthCare acute care hospital. Routinely covered by most insurance plans, the screening takes about 10 minutes and is painless.

“Most importantly, we know that this can save lives,” Dr. Salner said.

Need to know more about lung cancer? Click here to download your free guide.  

 


What's New

Ruth Bader Ginsburg

Lung Cancer: How a Lobectomy Works

You may recall Supreme Court Justice Ruth Bader Ginsburg recently underwent a lobectomy – a type of surgery to remove one of five lobes in her lungs. It’s a procedure that doctors at Hartford Hospital are performing more and more. Dr. Mario Katigbak, Chief of Thoracic Surgery at Hartford Hospital discusses this and...


Manchester Facility Brings Cancer, Other Services ‘East of the River’

Seeking to bring high-quality healthcare closer to people east of Hartford, Hartford HealthCare this month opened a $10.4-million, three-story building focused on delivering advanced cancer services and treatment while including the care of general and thoracic surgeons and urologists. “We know that bringing comprehensive cancer services into the community allows...

Cancer

Another New Cancer Drug Targets Tumors Based on Genetic Makeup

For the second time, the Food and Drug Administration has approved a drug treatment for patients with a specific genetic change in their tumor, regardless of the type of cancer. At Hartford Healthcare, Laila Mnayer, division director of Molecular Pathology and Cytogenetics, had already identified the importance of these fusion...

HPV

Ask a Doctor About HPV at These Free Seminars

Healthwise If You Have Symptoms When to Talk to Your Doctor Free Educational Seminars Learn more about HPV at one of these free educational seminars: Wednesday, March 27, at 5:30 p.m.: Gateway Medical Park (Education Room), 305 Western Blvd., Glastonbury. Click here to register. Wednesday, March 27, at 6:30 p.m.: Backus Hospital Main Lobby...


‘One for Everyone’ Donates to Avon Cancer Center

“What do we have in excess?” That was the simple question posed by a group of Avon seventh graders who had formed a charitable organization called One for Everyone. When the group was organized five years ago, the youth wanted to help those less fortunate but didn’t know what would...

HOCC adds endocrine surgeon.

Hospital of Central Connecticut Adds Dr. Carrie Carsello, Endocrine Surgeon

NEW BRITAIN – The Hospital of Central Connecticut (HOCC) has announced the addition of endocrine surgeon Dr. Carrie Carsello.  She is the only Hartford HealthCare surgeon who is fellowship trained in endocrine surgery, which treats conditions thyroid cancer, thyroid nodules, goiters, hyperparathyroidism, Graves’ disease and nodules, tumors, and cancer of...